Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its Non-Addictive Analgesic is an engineering non-addictive analgesic peptide for pain management. Its Dual Gene Therapy targets type 2 diabetes and obesity. The Company’s subsidiary, PreveCeutical (Australia) Pty Ltd., manages its research programs.

CSE:PREV - Post by User

Preveceutical Medical Inc > Prev webinar tomorrow

<< Previous

Bullboard Posts

Next >>

Comment by MrQuarterson Aug 19, 2020 8:18am

167 Views

Post# 31427047

RE:RE:RE:Prev webinar tomorrow

There was also mention of SIF funding which he said he is expecting shorty. Also that they do not intend to manufacture the drug, rather receive royalty for formula. However, even though he stressed that he doesn't want to implicate that this is for sure the company that will be doing the manufacturing he did mention Pfizer in his example.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1